T1	Pharmacological_substance 0 8	Warfarin
N1000 	Reference T1 MeSH:D014859	Warfarin
T2	Disorder 106 125	Chronic hepatitis C
N1 	Reference T2 UMLS:C0524910	Chronic hepatitis C
T3	Disorder 155 168	liver disease
N2 	Reference T3 UMLS:C0023895	liver disease
T4	Pharmacological_substance 170 189	Protease inhibitors
N1001 	Reference T4 MeSH:D011480	Protease inhibitors
T5	Pharmacological_substance 310 320	boceprevir
N1002 	Reference T5 MeSH:C512204	boceprevir
T6	Pharmacological_substance 325 333	warfarin
N1003 	Reference T6 MeSH:D014859	warfarin
T7	Disorder 472 483	hepatitis C
N3 	Reference T7 UMLS:C0019196	hepatitis C
T8	Disorder 565 585	deep vein thrombosis
N4 	Reference T8 UMLS:C0149871	deep vein thrombosis
T9	Disorder 590 608	pulmonary embolism
N5 	Reference T9 UMLS:C0034065	pulmonary embolism
T10	Pharmacological_substance 628 636	warfarin
N1004 	Reference T10 MeSH:D014859	warfarin
T12	Disorder 789 797	fibrosis
N6 	Reference T12 UMLS:C0016059	fibrosis
T13	Pharmacological_substance 855 876	peginterferon alfa-2a
N1005 	Reference T13 MeSH:C100416	peginterferon alfa-2a
T14	Pharmacological_substance 878 887	ribavirin
N1006 	Reference T14 MeSH:D012254	ribavirin
T15	Pharmacological_substance 931 941	boceprevir
N1007 	Reference T15 MeSH:C512204	boceprevir
T16	Pharmacological_substance 1028 1036	warfarin
N1008 	Reference T16 MeSH:D014859	warfarin
T18	Pharmacological_substance 1143 1153	boceprevir
N1009 	Reference T18 MeSH:C512204	boceprevir
T19	Pharmacological_substance 1216 1224	warfarin
N1010 	Reference T19 MeSH:D014859	warfarin
T21	Pharmacological_substance 1288 1298	boceprevir
N1011 	Reference T21 MeSH:C512204	boceprevir
T23	Disorder 1439 1455	thrombocytopenia
N7 	Reference T23 UMLS:C0040034	thrombocytopenia
T24	Pharmacological_substance 1481 1491	boceprevir
N1012 	Reference T24 MeSH:C512204	boceprevir
T25	Pharmacological_substance 1497 1505	warfarin
N1013 	Reference T25 MeSH:D014859	warfarin
T27	Pharmacological_substance 1642 1650	warfarin
N1014 	Reference T27 MeSH:D014859	warfarin
T29	Pharmacological_substance 1802 1810	warfarin
N1015 	Reference T29 MeSH:D014859	warfarin
T33	Pharmacological_substance 1950 1960	boceprevir
N1016 	Reference T33 MeSH:C512204	boceprevir
T34	Pharmacological_substance 1965 1973	warfarin
N1017 	Reference T34 MeSH:D014859	warfarin
T35	Pharmacological_substance 2049 2059	boceprevir
N1018 	Reference T35 MeSH:C512204	boceprevir
T36	Pharmacological_substance 2065 2073	warfarin
N1019 	Reference T36 MeSH:D014859	warfarin
T38	Pharmacological_substance 2191 2201	boceprevir
N1020 	Reference T38 MeSH:C512204	boceprevir
T39	Pharmacological_substance 2227 2235	warfarin
N1021 	Reference T39 MeSH:D014859	warfarin
T41	Pharmacological_substance 13 23	boceprevir
N1022 	Reference T41 MeSH:C512204	boceprevir
T11	Pharmacological_substance 892 902	boceprevir
N1023 	Reference T11 MeSH:C512204	boceprevir
T55	Disorder 828 839	hepatitis C
N8 	Reference T55 UMLS:C0019196	hepatitis C
T17	Disorder 1337 1348	hepatitis C
N9 	Reference T17 UMLS:C0019196	hepatitis C
T20	Disorder 44 89	subtherapeutic international normalized ratio
T26	Subject 418 452	A 73-year-old African American man
T31	Subject 811 818	patient
T40	Subject 543 545	he
T45	Speculation_cue 279 291	limited data
